Skip to the stories
Wednesday, 18 November 2026
Saved

Next edition

1:14

Headlines

Top Stories

Researchers develop DNA nanoswitch platform to screen protein interaction drug leads

Scientists have introduced a DNA nanoswitch platform called FIND that screens molecular libraries based on how candidate drugs alter protein-protein interactions.

FTMQ Science, written by our newsroom0 views

Share

Researchers at the Wyss Institute at Harvard University, Boston Children's Hospital, and Harvard Medical School have developed a drug discovery platform named FIND, Bioengineer.org reported. The technology uses DNA nanoswitches to screen large chemical libraries for molecules that alter protein-protein interactions, which are the binding events between two proteins. The team published their findings in the journal Science. [1]

Bioengineer.org reported that the platform selects drug candidates based on how they alter interactions between proteins rather than testing whether a molecule binds to a single target protein. Using this approach, the researchers identified new drug leads for diabetes and other health disorders. The screen successfully identified both small molecules and nanobodies. [1]

In pharmaceutical sciences, drug interactions occur when the mechanism of action of a drug is altered by the administration of other substances, including foods, beverages, or additional drugs. One established example of a drug-food interaction is the effect of grapefruit on drug metabolism. [2]

The discovery builds on broader efforts to engineer protein tools for therapeutic applications. As FTMQ Science reported earlier, researchers at the Institute for Protein Design and NVIDIA developed an artificial intelligence model called RFD4-Proteina to design custom protein sequences and structures five to 10 times faster than earlier software. [3]

Share

In short

  • Researchers at Harvard University institutions and Boston Children's Hospital created the FIND drug discovery platform.
  • The FIND platform uses DNA nanoswitches to test how molecules modulate protein-protein interactions.
  • Scientists used the platform to identify drug leads for diabetes, including small molecules and nanobodies.
  • The study describing the FIND platform was published in Science.

Sources

Every paragraph above points to the numbered items it rests on. Read the originals here.

  1. [1]DNA Nanoswitches Screen Protein Interactions for Drug LeadsBioengineer.org, 6d ago (the report this story comes from)

Background

  1. [2]Drug interaction on Wikipedia
  2. [3]AI model generates novel enzymes for drug synthesis FTMQ Science, 25d ago

Our newsroom writes these reports with the help of software, from the 3 sources listed and nothing else, and checks them against those sources. Facts can still be wrong or move on; the originals are the record. Spotted a mistake? Write to daniel@monsterkong.com.

Earlier reports of ours on the same people and subjects.

More in Top Stories

Get the day in one email

Reports like this one, the top news of the last 24 hours, every morning. Free, one email a day; readers can comment under every report.

By signing up you agree to our terms and privacy policy. Unsubscribe any time.

Comments

Loading

Join the conversation

Comments are open to readers of our daily email: the top news of the last 24 hours, every morning, free. Sign up and the comment box opens.

Already on the list? Enter the same address and we will send a sign-in link.

By signing up you agree to our terms and privacy policy. Unsubscribe any time.